00000000nam 2200000zi 4500
0019.908235
003CaOODSP
00520220812093710
006m     o  d f      
007cr mn|||||||||
008220217t20222022onca    o    f000 0 eng d
020 |a9780660421407
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
045 |ay2y2
0861 |aH14-391/2022E-PDF
24500|aOpioids overdose crisis brand and message focus testing : |bfinal report / |cprepared for Health Canada ; prepared by Narrative Research.
264 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2022.
264 4|c©2022
300 |a1 online resource (43, 11, 5, 9 pages) : |bcolour illustrations + |eexecutive summary (6 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Mise à l'essai de la marque et du message sur la crise des surdoses d'opioïdes : rapport final.
500 |a"PSPC Contract Number: HT372-214993/001/CY."
500 |a"POR number: 77-21."
500 |a"March 2022."
650 0|aOpioids|xOverdose|zCanada|xPrevention|xPublic opinion.
650 0|aOpioid abuse|zCanada|xPrevention|xPublic opinion.
650 0|aGovernment advertising|zCanada|xPublic opinion.
650 0|aAdvertising campaigns|zCanada|xPublic opinion.
650 0|aPublic opinion|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
7102 |aNarrative Research, |econsultant.
77508|tMise à l'essai de la marque et du message sur la crise des surdoses d'opioïdes : |w(CaOODSP)9.908236
85640|qPDF|s3.40 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H14-391-2022-eng.pdf|z(final report)
85640|qPDF|s221 KB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H14-391-2022-1-eng.pdf|z(executive summary)
8564 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2022/077-21-e/report.html|z(final report)
8564 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2022/077-21-e/summary/summary.html|z(executive summary)